The FDA has formally given the Plymouth medical company permission to begin selling its Edison technology for treating liver tumors.
Health Care + Med Tech
The Mayo Clinic-backed startup says it plans to use the funds to ramp up production of a new form of highly targeted cancer treatment.
Two out of three nursing home workers struggle to meet basic needs, according to a survey of 1,300 nursing home workers across the state.
The health care startup dedicated to women 65 and older plans to open even more clinics in 2024.
White Bear Lake-based Envoy Medical is now a publicly traded company after merging with a special purpose acquisition company, or SPAC.
Kyros, a platform that connects people to substance use disorder peer recovery specialists, will use the raise to expand service access.
Slated to close in the first quarter of 2024, the deal could include “additional contingent payments” based on Relievant’s sales.
The new group is tasked with helping improve education for medical workers in Minnesota.
The Eagan-based company aims to increase patient access to a new device designed to treat carpal tunnel syndrome faster and with less recovery time.
New Hampshire-based Laborie, which invested in Urotronic back in 2020, now plans to buy the company outright.
Because of the state's complex licensing requirements, some internationally trained mental health professionals say they haven’t been able to practice at a level equal to their education and experience since moving to the state.
The Minneapolis-based virtual clinic is on a mission to build a "comprehensive solution for women’s health care."
The funds will be used to finish development of a device to help women affected by stress urinary incontinence.
A Mayo Clinic spin-off, Pneumeric has developed a device to treat a collapsed lung in emergency scenarios.
Minnesotans need pathways to financial sustainability for Fairview Health and the U of M.
Focused on providing health care for women over 65 years old, Herself Health plans to add two more clinics in the Twin Cities area this year.
The Minneapolis-based health system said it’s facing “unprecedented financial challenges.”
The U.S. Food and Drug Administration has granted “breakthrough device designation” to two products developed by med-tech startup Fasikl.